ASCO 2022 Updates in HR+/HER2- eBC

 

ASCO 2022 Conference Coverage
M

ASCO 2022 on Estradiol Levels in Premenopausal Women With HR+ BC on Ovarian Function Suppression With GnRH Agonists

By ASCO 2022 Conference Coverage FEATURING Megan Tesch
By ASCO 2022 Conference Coverage FEATURING Megan Tesch
2,973 views
June 8, 2022
9 Comments
Login to view comments. Click here to Login
ASCO 2022 Updates in HR+/HER2- eBC
11:15
UNC Lineberger Comprehensive Cancer Center

Identifying High-Risk Patients to Guide Management in HR+/HER2- Earl…

Feat. Y. Abdou
08:45
Nadia Harbeck

Adjuvant Abemaciclib Combined With ET in HR+, HER2- High-Risk EBC: U…

07:17
ASCO 2022 Conference Coverage

ASCO 2022 Adjuvant Abemaciclib for High-Risk Early Breast Cancer: Fa…

Feat. S. Tolaney
54
ASCO 2022 Conference Coverage

Lecture Summary - ASCO 2022 Adjuvant Abemaciclib for High-risk Early…

Feat. S. Tolaney
08:04
ASCO 2022 Conference Coverage

ASCO 2022 on OPTIMA Preliminary Trial: Disparity Between Ki67 Measur…

Feat. R. Stein
05:15
Cedars Sinai

ASCO 2022: Identification of Transcriptional Changes With MammaPrint…

Feat. A. Chung
10:19
ASCO 2022 Conference Coverage

ASCO 2022 on Estradiol Levels in Premenopausal Women With HR+ BC on …

Feat. M. Tesch
32
ASCO 2022 Conference Coverage

Lecture Summary - ASCO 2022 on Estradiol Levels in Premenopausal Wom…

Feat. M. Tesch
31:43
Total Health

2022 MDONS Conference Breast Cancer Updates

Feat. F. Yan
13:32
ASCO 2022 Conference Coverage

ASCO 2022 on ABCSG-18 Trial: Long-Term Outcomes of Adjuvant Denosuma…

Feat. M. Gnant
05:13
ASCO 2022 Conference Coverage

ASCO 2022 Optimization of the Duration of Adjuvant Endocrine Therapy…

Feat. B. Pistilli
28
ASCO 2022 Conference Coverage

Lecture Summary - ASCO 2022 Optimization of the Duration of Adjuvant…

Feat. B. Pistilli
05:00
ecancer

ASCO 2022 on the Adjuvant Endocrine Therapy for ER+/HER2- Breast Can…

Feat. E. Brain
22:29
ESMO 2022 Conference Coverage

ESMO 2022 on Adjuvant Endocrine Therapy for BC: Who Needs More Than …

Feat. E. de Azambuja